Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name FLYING EAGLE ACQUISITION CORP Proposed Ticker N/A CUSIP N/A Business Description disease-modifying treatment for sickle cell disease, or SCD, and B-thalassemia Lead Underwriter Goldman Sachs & Co. LLC Co-Managers N/A Initial Shares 50,000,000 Revised Initial Shares N/A Initial Price $10.00-$10.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.